Orhan Demir
Military Medical Academy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Orhan Demir.
Angiology | 2013
Mustafa Inanc Dogan; Ilker Tasci; Fatih Bulucu; Aydogan Aydogdu; Ramazan Acar; Temel Ceyhan; Bayram Koc; Orhan Demir; Mustafa Gezer; Kenan Saglam
Polycystic ovary syndrome (PCOS) was linked to increased lifetime risk of cardiovascular disease. A low ankle–brachial index (ABI) is associated with accelerated atherosclerosis. The ABI value and the associated conditions in women with PCOS were searched in the present study. The ABI was measured using a handheld Doppler device and calculated using both standard and modified definitions. Women with PCOS (n = 103, mean age = 24.9 ± 5.9 years) had a mean ABI of 1.10 ± 0.10. A low ABI (≤0.9) was 2.9% and 14.6% using the standard and modified definitions, respectively. Mean ABI correlated negatively to body weight, BMI, waist circumference, waist-to-hip ratio, and hematocrit. Logistic regression analysis revealed higher waist-to-hip ratio as independently associated with a lower ABI. Frequency of ABI ≤0.9 in PCOS was lower than the general population. However, increased waist-to-hip ratio was a predictor of a lower ABI value.
Experimental and Clinical Endocrinology & Diabetes | 2017
Alper Sonmez; Mustafa Dinc; Abdullah Taslipinar; Aydogan Aydogdu; Coskun Meric; Yalcin Basaran; Cem Haymana; Orhan Demir; Ilker Yilmaz; Omer Azal
Background: Intensive insulin treatment is bothersome in obese patients with type 2 diabetes mellitus. High insulin dosages further increase weight gain and the risk of hypoglycemia. Glucagon like peptide-1 receptor agonists decrease the insulin need, cause weight loss and reduce the risk of hypoglycemia. There is limited data about the effect of exenatide on obese diabetics under intensive insulin regimens. Methods: This retrospective case series report the clinical outcomes of 23 obese (13 morbidly obese) patients with uncontrolled type 2 diabetes mellitus (Age=59±10.44 years, body mass index 41.1±6.8 kg/m2, HbA1c 9.9±1.5%), under high dose (94.1±39.6 unit) intensive insulin. Exenatide twice daily was added for a mean follow-up period of 11.22±7.01 (3-30) months. Intensive insulin regimens were continued in 7 patients while the others were switched to basal insulin during the follow-up. Results: During the follow-up, mean HbA1c levels of the patients significantly improved (p=0.019), along with the significant decrease in body mass index and the total insulin need (p<0.001 for both). Baseline insulin dosages were significantly higher in the intensive regimen group (p=0.013) while other demographical and clinical characteristics were similar. No significant difference was present between the groups regarding the alterations of HbA1c, body mass index and the reduction in total insulin dosages. Conclusion: Add on exenatide appears to be a rational treatment modality in uncontrolled obese patients with type 2 diabetes mellitus despite intensive insulin regimens. Further prospective randomized studies with longer follow-up periods are recommended.
Endocrine‚ Metabolic & Immune Disorders-Drug Targets | 2018
Cem Haymana; Aydogan Aydogdu; Ibrahim Demirci; Mustafa Dinc; Orhan Demir; Deniz Torun; Fatih Yesildal; Coskun Meric; Yalcin Basaran; Alper Sonmez; Omer Azal
BACKGROUND AND OBJECTIVE Patients with Klinefelter Syndrome (KS) have increased cardiometabolic risk however the pathogenesis is not clear. We investigated the presence of endothelial dysfunction, insulin resistance and inflammation in an unconfounded population of KS. METHODS A total of 32 patients with KS (mean age 21.59 ± 1.66 years) and 33 healthy control subjects (mean age: 22.15 ± 1.03 years) were enrolled. The demographic parameters, Asymmetric dimethylarginine (ADMA), homeostatic model assessment of insulin resistance (HOMA-IR) index and highsensitivity C-reactive protein (hs-CRP) levels were measured. RESULTS The patients had higher Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), insulin, HOMA-IR and ADMA levels (p < 0.001 for all) and lower High Density Lipoprotein Cholesterol (HDL-C) and total testosterone levels (p=0.002 and p<0.001, respectively), compared to the healthy controls. Total testosterone levels were significantly negatively correlated to ADMA (r = - 0.479, p < 0,001), hs-CRP (r = -0.291, p = 0.034) and positively correlated to HDL-C (r = 0.429, p = 0.001) levels. The multivariate analysis has shown that total testosterone (β = -0.412, p = 0.001) and TG (β = 0.332, p = 0.009) levels were the significant independent determinants of the plasma ADMA levels. CONCLUSION The results of the present study show that endothelial dysfunction and insulin resistance are prevalent even in the very young subjects with KS, who have no metabolic or cardiac problems at present. Also, hypogonadism seems to play an important role for increased cardiometabolic risk in patients with KS.
American Journal of Alzheimers Disease and Other Dementias | 2018
Ilker Tasci; Umut Safer; Mehmet Ilkin Naharci; Mustafa Gezer; Orhan Demir; Ergun Bozoglu; Huseyin Doruk
Background: Peripheral arterial disease (PAD) was reported to increase the risk of dementia(s) even more than stroke. We assessed the prevalence of PAD in a group with definite diagnosis of dementia. Methods: Patients aged 65 years or older with Alzheimer’s disease (AD), vascular dementia (VaD), or AD-VaD were enrolled (n = 162, mean age: 78.87 [6.05] years). An age- and gender-matched control group was also included (n = 190). Peripheral arterial disease was diagnosed by the ankle–brachial index. Results: Frequency of PAD among patients with and without dementia was 35.2% and 16.3%, respectively (P < .001), being similar among different types of dementia. After adjustment for covariates, dementia (odds ratio: 2.41, 95% confidence interval: 1.34-4.32; P = .003) was among the predictors of PAD diagnosis along with older age, female gender, and diabetes. Conclusions: The prevalence of PAD was more than double in patients with dementia, with no difference among AD, VaD, and AD-VaD types.
Vascular | 2016
Orhan Demir; Ilker Tasci; Cengizhan Acikel; Kenan Saglam; Mustafa Gezer; Ramazan Acar; Birol Yildiz; Fatih Bulucu; Hasan Kutsi Kabul; Mustafa Inanc Dogan; Bayram Koc
Purpose Variability of ankle brachial index (ABI) measured by the same observer in the same individual on three different occasions was examined. Basic methods A single morning ABI was initially determined (measurement 1) with handheld Doppler device. One to four weeks apart, another morning (measurement 2) and afternoon (measurement 3) ABI was measured on the same day. Principal findings A total of 161 adults were enrolled. Mean ABI was similar among the three measurements. ABI differed more than ≥0.15 in 15 individuals between measurement 1 and 3, in 10 subjects between measurement 1 and 2, and in 12 individuals between measurement 2 and 3. Intra-group correlation coefficients of reproducibility of ABI were 0.808 for single measurements (coefficient of the values lacking association with each other), and 0.927 for average measurements (coefficient of the values that were associated with each other). Conclusions Although reproducibility of ABI values was found satisfactory, up to 12% of participants displayed more than 0.15 alternations between measurements, either on the same day or more than a week apart.
Endocrine Abstracts | 2018
Ibrahim Demirci; Cem Haymana; Yusuf Alper Sonmez; Abdullah Bolu; Nazli Gulsoy Kirnap; Orhan Demir; Mustafa Dinc; Coskun Meric; Aydogan Aydogdu; Omer Azal
20th European Congress of Endocrinology | 2018
Cem Haymana; Ibrahim Demirci; Mustafa Dinc; Orhan Demir; Onur Akın; Coskun Meric; Aydogan Aydogdu; Alper Sonmez; Omer Azal
20th European Congress of Endocrinology | 2018
Ibrahim Demirci; Cem Haymana; Orhan Demir; Nazli Gulsoy Kirnap; Coskun Meric; Yusuf Alper Sonmez; Nese Ersoz Gulcelik; Aydogan Aydogdu; Omer Azal
20th European Congress of Endocrinology | 2018
Ibrahim Demirci; Cem Haymana; Nese Ersoz Gulcelik; Yusuf Alper Sonmez; Coskun Meric; Aydogan Aydogdu; Orhan Demir; Omer Azal
Gulhane Medical Journal | 2017
Cem Haymana; Alper Sonmez; Aydogan Aydogdu; Abdullah Taslipinar; Serkan Tapan; Coskun Meric; Yalcin Basaran; Mustafa Dinc; Orhan Demir; Omer Azal